{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:44:02Z","timestamp":1791438242230,"version":"4.3.3"},"reference-count":101,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015112","name":"Melza M. and Frank Theodore Barr Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R01EY020878"],"award-info":[{"award-number":["1R01EY020878"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R01EY023621"],"award-info":[{"award-number":["1R01EY023621"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001641","name":"Glaucoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007044","name":"Macula Vision Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007044","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ymthe.2018.08.017","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T23:39:53Z","timestamp":1535067593000},"page":"2379-2396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma"],"prefix":"10.1016","volume":"26","author":[{"given":"Alejandra","family":"Bosco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar O.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince A.","family":"Chiodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford L.","family":"Boye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Hauswirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.08.017_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","article-title":"Critical pathogenic events underlying progression of neurodegeneration in glaucoma","volume":"31","author":"Calkins","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib2","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2018.08.017_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.10.001","article-title":"Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma","volume":"56","author":"De Moraes","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exer.2016.12.005","article-title":"Neuroprotection for glaucoma: Requirements for clinical translation","volume":"157","author":"Levin","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib5","doi-asserted-by":"crossref","first-page":"a017269","DOI":"10.1101\/cshperspect.a017269","article-title":"The complex role of neuroinflammation in glaucoma","volume":"4","author":"Soto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ymthe.2018.08.017_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exer.2017.02.014","article-title":"Neuroinflammation in glaucoma: A new opportunity","volume":"157","author":"Williams","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 - The \u201cSwiss Army Knife\u201d of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2018.08.017_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2017.05.025","article-title":"C1q: A fresh look upon an old molecule","volume":"89","author":"Thielens","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.arr.2013.02.001","article-title":"From development to dysfunction: microglia and the complement cascade in CNS homeostasis","volume":"12","author":"Zabel","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ymthe.2018.08.017_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fncel.2014.00380","article-title":"Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis","volume":"8","author":"Orsini","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fimmu.2015.00417","article-title":"Complement in the Homeostatic and Ischemic Brain","volume":"6","author":"Alawieh","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","article-title":"Retinal microglia: just bystander or target for therapy?","volume":"45","author":"Karlstetter","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1167\/iovs.05-0830","article-title":"Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes","volume":"47","author":"Stasi","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib16","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1167\/iovs.10-5289","article-title":"Oxidative stress and the regulation of complement activation in human glaucoma","volume":"51","author":"Tezel","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib17","doi-asserted-by":"crossref","first-page":"12685","DOI":"10.1038\/s41598-017-12858-7","article-title":"Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes","volume":"7","author":"Mirzaei","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2018.08.017_bib18","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1167\/iovs.15-17294","article-title":"Proteomics Analysis of Molecular Risk Factors in the Ocular Hypertensive Human Retina","volume":"56","author":"Yang","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.exer.2006.03.002","article-title":"Retinal synthesis and deposition of complement components induced by ocular hypertension","volume":"83","author":"Kuehn","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib20","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1167\/iovs.02-1032","article-title":"Gene microarray analysis of experimental glaucomatous retina from cynomologous monkey","volume":"44","author":"Miyahara","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1167\/iovs.03-1123","article-title":"Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure","volume":"45","author":"Ahmed","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib22","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1167\/iovs.06-1282","article-title":"Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model","volume":"48","author":"Johnson","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib23","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1167\/iovs.09-3560","article-title":"Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA\/2J mice","volume":"51","author":"Panagis","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1167\/iovs.05-0865","article-title":"Microarray analysis of retinal gene expression in the DBA\/2J model of glaucoma","volume":"47","author":"Steele","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2018.08.017_bib26","doi-asserted-by":"crossref","first-page":"E3839","DOI":"10.1073\/pnas.1608769114","article-title":"Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective","volume":"114","author":"Harder","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.08.017_bib27","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI44646","article-title":"Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma","volume":"121","author":"Howell","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.08.017_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2014.07.016","article-title":"Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma","volume":"71","author":"Howell","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2018.08.017_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exer.2015.06.019","article-title":"Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities","volume":"141","author":"Fernandes","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib30","doi-asserted-by":"crossref","first-page":"e0142199","DOI":"10.1371\/journal.pone.0142199","article-title":"Differential Effects of C1qa Ablation on Glaucomatous Damage in Two Sexes in DBA\/2NNia Mice","volume":"10","author":"Kumari","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.08.017_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-2094-10-76","article-title":"Deficiency of complement component 5 ameliorates glaucoma in DBA\/2J mice","volume":"10","author":"Howell","year":"2013","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2018.08.017_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.it.2017.03.003","article-title":"Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery","volume":"38","author":"Mastellos","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.smim.2016.05.007","article-title":"New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities","volume":"28","author":"Holers","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/imr.12470","article-title":"Injury site-specific targeting of complement inhibitors for treating stroke","volume":"274","author":"Alawieh","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2018.08.017_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00018-002-8418-6","article-title":"The murine complement regulator Crry: new insights into the immunobiology of complement regulation","volume":"59","author":"Molina","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.175.1.121","article-title":"Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1","volume":"175","author":"Molina","year":"1992","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2018.08.017_bib37","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.4049\/jimmunol.163.12.6551","article-title":"Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis","volume":"163","author":"Davoust","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib38","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1167\/iovs.08-3202","article-title":"Expression and modulation of RPE cell membrane complement regulatory proteins","volume":"50","author":"Yang","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib39","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1172\/JCI25208","article-title":"Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection","volume":"115","author":"Atkinson","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.08.017_bib40","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.4049\/jimmunol.177.10.7266","article-title":"Complement-dependent P-selectin expression and injury following ischemic stroke","volume":"177","author":"Atkinson","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12974-015-0464-8","article-title":"Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement","volume":"12","author":"Alawieh","year":"2015","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2018.08.017_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2012.10.012","article-title":"Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE","volume":"531","author":"Hu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymthe.2018.08.017_bib43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2353\/ajpath.2006.060248","article-title":"Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma","volume":"169","author":"Qiao","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib44","doi-asserted-by":"crossref","first-page":"e19078","DOI":"10.1371\/journal.pone.0019078","article-title":"A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration","volume":"6","author":"Cashman","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.08.017_bib45","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1073\/pnas.1620299114","article-title":"Complement modulation in the retinal pigment epithelium rescues photoreceptor degeneration in a mouse model of Stargardt disease","volume":"114","author":"Lenis","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.08.017_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/gt.2014.24","article-title":"AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in mice","volume":"21","author":"Birke","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2018.08.017_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/mt.2010.234","article-title":"Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina","volume":"19","author":"Petrs-Silva","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.08.017_bib48","first-page":"1331","article-title":"Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma","volume":"16","author":"Ju","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2018.08.017_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/mt.2015.198","article-title":"Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma","volume":"24","author":"Bond","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.08.017_bib50","doi-asserted-by":"crossref","first-page":"e0144341","DOI":"10.1371\/journal.pone.0144341","article-title":"Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma","volume":"10","author":"Berry","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.08.017_bib51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.omtm.2017.04.008","article-title":"Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA\/2J Mice","volume":"5","author":"Cwerman-Thibault","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2018.08.017_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S095252380999023X","article-title":"A Thy1-CFP DBA\/2J mouse line with cyan fluorescent protein expression in retinal ganglion cells","volume":"26","author":"Raymond","year":"2009","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.08.017_bib54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.08.017_bib55","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI65861","article-title":"Detection of complement activation using monoclonal antibodies against C3d","volume":"123","author":"Thurman","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.08.017_bib56","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1523\/JNEUROSCI.04-08-02025.1984","article-title":"Antibodies against filamentous components in discrete cell types of the mouse retina","volume":"4","author":"Dr\u00e4ger","year":"1984","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1083\/jcb.200506099","article-title":"Retinal ganglion cell degeneration is topological but not cell type specific in DBA\/2J mice","volume":"171","author":"Jakobs","year":"2005","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib58","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.08.017_bib59","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2197-17.2018","article-title":"Identifying the role of complement in triggering neuroinflammation after traumatic brain injury","author":"Alawieh","year":"2018","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib60","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1167\/iovs.17-21672","article-title":"Retinal Macrophages Synthesize C3 and Activate Complement in AMD and in Models of Focal Retinal Degeneration","volume":"58","author":"Natoli","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib61","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/glia.23090","article-title":"Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis","volume":"65","author":"Michailidou","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2018.08.017_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.21524","article-title":"Immunoglobulins and complement in postmortem multiple sclerosis tissue","volume":"65","author":"Barnett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib63","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","article-title":"Immunopathology of secondary-progressive multiple sclerosis","volume":"50","author":"Prineas","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib64","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S0952523805225130","article-title":"Inherited glaucoma in DBA\/2J mice: pertinent disease features for studying the neurodegeneration","volume":"22","author":"Libby","year":"2005","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib65","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1073\/pnas.0407357102","article-title":"High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma","volume":"102","author":"Anderson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.08.017_bib66","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1523\/JNEUROSCI.3714-07.2008","article-title":"Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model","volume":"28","author":"Soto","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib67","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1523\/JNEUROSCI.4443-07.2008","article-title":"Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma","volume":"28","author":"Buckingham","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib68","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cne.22516","article-title":"Early microglia activation in a mouse model of chronic glaucoma","volume":"519","author":"Bosco","year":"2011","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib69","doi-asserted-by":"crossref","first-page":"e115579","DOI":"10.1371\/journal.pone.0115579","article-title":"Rescue of retinal function by BDNF in a mouse model of glaucoma","volume":"9","author":"Domenici","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.08.017_bib70","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1083\/jcb.200706181","article-title":"Axons of retinal ganglion cells are insulted in the optic nerve early in DBA\/2J glaucoma","volume":"179","author":"Howell","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib71","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fnins.2016.00494","article-title":"Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA\/2J Mouse Model of Glaucoma","volume":"10","author":"Wilson","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib72","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1242\/dmm.018788","article-title":"Neurodegeneration severity can be predicted from early microglia alterations monitored in\u00a0vivo in a mouse model of chronic glaucoma","volume":"8","author":"Bosco","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2018.08.017_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exer.2016.01.014","article-title":"Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma","volume":"150","author":"Bosco","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib74","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2018.08.017_bib75","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.smim.2016.06.001","article-title":"New milestones ahead in complement-targeted therapy","volume":"28","author":"Ricklin","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib76","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib77","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.imbio.2012.08.232","volume":"217","author":"Holers","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.ymthe.2018.08.017_bib78","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.181.5.2953","article-title":"Comparative functional evolution of human and mouse CR1 and CR2","volume":"181","author":"Jacobson","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib79","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI17348","article-title":"Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation","volume":"111","author":"Song","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.08.017_bib80","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1201904","article-title":"The alternative complement pathway propagates inflammation and injury in murine ischemic stroke","volume":"189","author":"Elvington","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib81","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/1743-422X-9-285","article-title":"A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor","volume":"9","author":"Qiu","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2018.08.017_bib82","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnins.2017.00174","article-title":"Retinal Gene Therapy: Surgical Vector Delivery in the Translation to Clinical Trials","volume":"11","author":"Ochakovski","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib83","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1167\/iovs.17-22473","article-title":"Superior Retinal Gene Transfer and Biodistribution Profile of Subretinal Versus Intravitreal Delivery of AAV8 in Nonhuman Primates","volume":"58","author":"Seitz","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib84","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.ymthe.2017.08.018","article-title":"AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye","volume":"25","author":"Reichel","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.08.017_bib85","doi-asserted-by":"crossref","first-page":"E95","DOI":"10.1073\/pnas.1618157114","article-title":"The brain parenchyma has a type I interferon response that can limit virus spread","volume":"114","author":"Drokhlyansky","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.08.017_bib86","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1523\/JNEUROSCI.2801-06.2006","article-title":"Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma","volume":"26","author":"Nakazawa","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2017.03.003","article-title":"Unravelling the genetics of inherited retinal dystrophies: Past, present and future","volume":"59","author":"Broadgate","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib88","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpb.2015.01.009","article-title":"Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications","volume":"95","author":"Sch\u00f6n","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ymthe.2018.08.017_bib89","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ymthe.2017.03.008","article-title":"Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward","volume":"25","author":"Bennett","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.08.017_bib90","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.08.017_bib91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.exer.2008.04.012","article-title":"Disruption of the complement cascade delays retinal ganglion cell death following retinal ischemia-reperfusion","volume":"87","author":"Kuehn","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib92","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1073\/pnas.0913141107","article-title":"Distal axonopathy with structural persistence in glaucomatous neurodegeneration","volume":"107","author":"Crish","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.08.017_bib93","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.exer.2008.12.002","article-title":"Mouse models of retinal ganglion cell death and glaucoma","volume":"88","author":"McKinnon","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2018.08.017_bib94","first-page":"5926906","article-title":"Molecular Genetics of Pigment Dispersion Syndrome and Pigmentary Glaucoma: New Insights into Mechanisms","volume":"2018","author":"Lahola-Chomiak","year":"2018","journal-title":"J.\u00a0Ophthalmol."},{"key":"10.1016\/j.ymthe.2018.08.017_bib95","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2018.08.017_bib96","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fnins.2016.00526","article-title":"Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma","volume":"10","author":"Breen","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2018.08.017_bib97","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2018.08.017_bib98","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymthe.2018.08.017_bib99","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1074\/jbc.M110.191866","article-title":"Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration","volume":"286","author":"Radu","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2018.08.017_bib100","doi-asserted-by":"crossref","first-page":"e43602","DOI":"10.1371\/journal.pone.0043602","article-title":"Early reduction of microglia activation by irradiation in a model of chronic glaucoma","volume":"7","author":"Bosco","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.08.017_bib101","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1167\/iovs.07-1337","article-title":"Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment\u00a0in the DBA\/2J mouse model of glaucoma","volume":"49","author":"Bosco","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618304209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618304209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:46:34Z","timestamp":1777617994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618304209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1525001618304209"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.08.017","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/369181","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}